A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

NCT04876456 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Tumor
Seminoma
Non-seminomatous Germ Cell Tumor
Ovarian Germ Cell Tumor

Interventions

DRUG: Cabozantinib

Sponsor

Jennifer King

Collaborators

[object Object]
[object Object]